Current Medicinal Chemistry

Meet Our Editorial Board Member
pp. 3205-3205(1)
Author: Faggio, Caterina

Enzyme Inhibitors as the Attractive Targets for the Treatment of Various Diseases
pp. 3206-3207(2)
Author: Orhan, Ilkay E.

Perspectives and New Aspects of Metalloproteinases’ Inhibitors in the Therapy of CNS Disorders: From Chemistry to Medicine
pp. 3208-3224(17)
Authors: Boguszewska-Czubara, Anna; Budzynska, Barbara; Skalicka-Wozniak, Krystyna; Kurzepa, Jacek

Cyclooxygenase-2 Inhibitors as a Therapeutic Target in Inflammatory Diseases
pp. 3225-3241(17)
Authors: Ferrer, Miguel D.; Busquets-Cortés, Carla; Capó, Xavier; Tejada, Silvia; Tur, Josep A.; Pons, Antoni; Sureda, Antoni

Lactate Dehydrogenase Inhibition: Biochemical Relevance and Therapeutical Potential
pp. 3242-3252(11)
Authors: Laganà, Giuseppina; Barreca, Davide; Calderaro, Antonella; Bellocco, Ersilia

Aporphines and Alzheimer’s Disease: Towards a Medical Approach Facing the Future
pp. 3253-3259(7)
Authors: Nabavi, Seyed M.; Uriarte, Eugenio; Rastrelli, Luca; Sobarzo-Sánchez, Eduardo

Benzimidazole-derived Compounds Designed for Different Targets of Alzheimer’s Disease
pp. 3260-3278(19)
Authors: Gulcan, Hayrettin O.; Mavideniz, Açelya; Sahin, Mustafa Fethi; Orhan, Ilkay Erdogan

Advances in the Tyrosinase Inhibitors from Plant Source
pp. 3279-3299(21)
Authors: Bonesi, Marco; Xiao, Jianbo; Tundis, Rosa; Aiello, Francesca; Sicari, Vincenzo; Loizzo, Monica R.

Innovative Therapeutic Potential of Cannabinoid Receptors as Targets in Alzheimer’s Disease and Less Well-Known Diseases
pp. 3300-3340(41)
Authors: Páez, Juan A.; Campillo, Nuria E.

Metal–Organic Framework (MOF)-based Nanomaterials for Biomedical Applications
pp. 3341-3369(29)
Authors: Luo, Zhidong; Fan, Shuran; Gu, Chuying; Liu, Weicong; Chen, Jinxiang; Li, Baohong; Liu, Jianqiang